StonvexLoading…
StonvexStonvexStonvexCore line items from TJX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-19 | Q2 2026 2026-05-02 | Annual 2026 2026-01-31 | Q4 2025 2025-11-01 | Q3 2025 2025-08-02 |
|---|---|---|---|---|---|
Revenue | $15.33B | $14.32B | $60.37B | $42.63B | $27.51B |
Operating Income | Not available | $1.72B | $7.30B | $4.91B | $2.99B |
Net Income | Not available | $1.33B | $5.49B | $3.72B | $2.28B |
EPS (Diluted) | $1.20 | $1.19 | $4.87 | $3.30 | $2.02 |
Total Assets | Not available | $36.16B | $35.77B | $35.19B | $32.88B |
Total Liabilities | Not available | Not available | Not available | Not available | Not available |
Cash & Equivalents | Not available | $5.58B | $6.23B | $4.64B | $4.64B |
Free Cash Flow OCF − CapEx | Not available | $457.00M | $4.92B | $2.23B | $1.23B |
Shares Outstanding | Not available | 1.11B | 1.11B | 1.11B | 1.11B |